Upload
marcos-marques
View
215
Download
1
Embed Size (px)
Citation preview
RESEARCH PAPER
Gold nanoparticles induce DNA damage in the bloodand liver of rats
Eria Cardoso • Eduardo Londero • Gabriela Kozuchovski Ferreira •
Gislaine Tezza Rezin • Elton Torres Zanoni • Frederico de Souza Notoya •
Daniela Dimer Leffa • Adriani Paganini Damiani • Francine Daumann •
Paula Rohr • Luciano da Silva • Vanessa M. Andrade • Marcos Marques da Silva Paula
Received: 5 August 2014 / Accepted: 30 October 2014
� Springer Science+Business Media Dordrecht 2014
Abstract The potential of gold nanoparticles
(GNPs) for use in different biological applications
has led to a strong interest in the study of their possible
deleterious effects in biological systems and how these
effects may be mitigated. This study was undertaken
to investigate the effects of the acute and chronic
administration of GNPs with mean diameters of 10
and 30 nm on deoxyribonucleic acid (DNA) damage
in the blood and liver of adult rats. For the acute
administration, Wistar adult rats received a single
intraperitoneal injection of either GNPs or a saline
solution. For the chronic administration, Wistar adult
rats received a daily single injection of the same GNPs
or saline solution for 28 days. Twenty-four hours after
either the single (acute) or final injection (chronic), the
rats were euthanised by decapitation, and the blood
and liver were isolated for the evaluation of DNA
damage. In this study, we demonstrated that the acute
and chronic administration of GNPs 10 and 30 nm in
size increased the frequency of DNA damage and the
damage index in the blood and liver of adult rats.
These findings suggest that the DNA damage may be
caused by oxidative stress, which occurred regardless
of the type of administration and GNP size.
Keywords Gold nanoparticles � DNA damage �Comet assay � Blood � Liver
Introduction
Gold nanoparticles (GNPs) possess unique properties,
such as biocompatibility, high surface reactivity,
resistance to oxidation, flexibility in functionalisation
and a wide range of delivery targets (Sonavane et al.
2008; Aschner 2009; Zhang et al. 2010). GNPs are
useful for the delivery and controlled release of a
variety of chemical agents, including anticancer drugs,
antibiotics, amino acids, peptides, glucose, antioxi-
dants, nucleic acids and isotopes (Oberdorster et al.
2005). Although GNPs are recognised as being as
E. Cardoso � E. Londero � G. K. Ferreira �E. T. Zanoni � F. de Souza Notoya �L. da Silva � M. M. da Silva Paula (&)
Laboratorio de Sıntese de Complexos Multifuncionais,
PPGCS, Universidade do Extremo Sul Catarinense,
Criciuma, SC 88806-000, Brazil
e-mail: [email protected]
E. Cardoso
Instituto Federal de Educacao, Ciencia e Tecnologia
Catarinense, Campus Sombrio, Sombrio, SC 88960-000,
Brazil
G. T. Rezin
Laboratorio de Fisiopatologia Clınica e Experimental,
PPGCS, Universidade do Sul de Santa Catarina, Tubarao,
SC 88704-9000, Brazil
D. D. Leffa � A. P. Damiani � F. Daumann �P. Rohr � V. M. Andrade
Laboratorio de Biologia Celular e Molecular, PPGCS,
Universidade do Extremo Sul Catarinense, Av.
Universitaria, 1105, Criciuma, SC 88806-000, Brazil
123
J Nanopart Res (2014) 16:2727
DOI 10.1007/s11051-014-2727-1
nontoxic (Merchant 1998; Connor et al. 2005; Shukla
et al. 2005), some reports have suggested that they are
toxic; this has been shown to depend on the physical
dimensions, surface chemistry and shape of the GNPs.
Their potential for use in different biological applica-
tions has led to a strong interest in the study of their
possible deleterious effects in biological systems and
how these effects may be mitigated (Pernodet et al.
2006; Chithrani and Chan 2007; Pan et al. 2007).
Sonavane et al. (2008) demonstrated the presence
of a wide distribution of gold particles inside the living
system. Additionally, Sadauskas et al. (2007) studied
the biodistribution of colloidal GNPs administered
intravenously and intraperitoneally to adult female
mice. In all of the mice exposed to the GNPs,
accumulations of nanoparticles were traced to Kupffer
cells, i.e. the macrophages of the liver. No accumu-
lation was observed in cells other than macrophages in
any of the organs examined in this study. However, it
is essential to understand the interactions of GNPs
with vital organs, such as the blood and liver (de
Lamirande and Gagnon 1993; Sadauskas et al. 2007;
Sadauskas et al. 2009).
Studies have strongly focused on the potential of
nanomaterials to cause oxidative stress (de Lamirande
and Gagnon 1993; Butterfield and Stadtman 1997;
Porter and Janicke 1999; Karihtala et al. 2009; Ng
et al. 2010), and an excessive production of reactive
oxygen species (ROS) can lead to reactions with
macromolecules, such as deoxyribonucleic acid
(DNA), lipids and proteins. It has been proposed that
DNA damage contributes to cellular dysfunction.
Cellular DNA is a sensitive target of damage follow-
ing oxidative stress. This damage can include chem-
ical and structural modifications to purine and
pyrimidine bases and 20-deoxyribose and the forma-
tion of single- and double-strand breaks. Strand breaks
within DNA can occur either directly, due to damage
from free radical exposure, or indirectly, due to the
cleavage of the DNA backbone during base excision
repair (BER) (Liu and Martin 2001; Martin and Liu
2002). Continued oxidative damage to DNA can alter
signalling cascades and gene expression and cause
replication errors and genomic instability (Karihtala
et al. 2009). The comet assay, which is also called
single-cell gel electrophoresis, is considered to be the
most sensitive quantitative method for measuring
early damage to the genomic DNA of eukaryotic cells
or disaggregated tissues (Ng et al. 2010; Collins 2014).
Because the widespread use of nanoparticles (NPs)
in the future will probably have an enormous impact
on human health, it is essential to understand their
effects on the blood and liver. This study was
undertaken to investigate the effects of the acute and
chronic administration of GNPs with mean diameters
of 10 and 30 nm on DNA damage in the blood and
livers of adult rats using the alkaline comet assay.
Materials and methods
Synthesis and characterisation of gold
nanoparticles
GNPs of both 10 and 30 nm were synthesised as
described by Turkevich et al., with minor modifica-
tions (CooperaStevenson 1951). Tetrachloroauric acid
(HAuCl4) was acquired from Sigma-Aldrich (St.
Louis, MO, USA), and sodium citrate (Na3C6H5O7.2-
H2O), which is a reducing agent and stabiliser, was
acquired from Nuclear (Diadema, SP, Brazil). GNP
size was controlled using distinct sodium citrate
concentrations. Initially, 100 ml of 0.50 mM tetra-
chloroauric acid was transferred to a round-bottomed
flask and heated to 90 �C with mechanical stirring at
700 rpm. The sodium citrate solution was then added,
and the system was stirred at 90 �C for another
20 min. Sodium citrate solutions at concentrations of
136.0 and 8.5 mM were used to obtain GNPs-10 and
GNPs-30, respectively. The 10 and 30 nm GNPs
possessed pH values of 6.5 and 2.8, respectively. The
pH values of both were adjusted to physiologic pH
with a buffer solution. Next, the GNP solutions were
centrifuged (13,000 rpm for 15 min), washed twice
with ultrapure water and dispersed in saline solution.
The electronic spectra were obtained using a Shima-
dzu instrument model UV-1800 (Shimadzu Corp.,
Kyoto, Japan), which showed SPR (surface plasmon
resonance) bands with kmax values of 517 and 547 nm
for GNPs-10 and GNPs-30, respectively. X-ray dif-
fraction measurements were performed to determine
the mean diameters of GNPs-10 and GNPs-30, which
were calculated using Scherer’s equation from the
signal at 2h = 38� (major relative intensity) (Hirn
et al. 2011). These values were confirmed by the
transmission electron microscopy (TEM) analysis
images obtained using a JEOL Titan 80–300 kV.
The Au concentrations were measured by atomic
2727 Page 2 of 8 J Nanopart Res (2014) 16:2727
123
absorption spectroscopy (AAS) (Varian model AA
240Z; Varian Medical Systems, Inc., Palo Alto, CA,
USA). The value obtained for both original solutions
was 70 mg l-1. The zeta potentials of the solutions
were also measured (Zeta Potential Analyser, Zeta
PALS Brookhaven Instruments, Holtsville, NY, USA)
at 25 �C, and the values at -30 and -35 mV for
GNPs-10 and GNPs-30, respectively, were obtained.
After all of the characterisation tests, we observed that
the GNPs were compliant with previous reports by
Cardoso et al. (2014).
Animals
Adult (60 days old) male Wistar rats (250–300 g) were
obtained from the central animal house of the Univer-
sidade do Extremo Sul Catarinense. A total of 36
animals were used and were divided into six animals per
group. The animals had free access to food and water
and were maintained on a 12-h light–dark cycle (lights
on 7:00 am) at 23 ± 1 �C. All experimental procedures
were carried out in accordance with the National
Institutes of Health Guide for the Care and Use of
Laboratory Animals and the Brazilian Society for
Neuroscience and Behavior (SBNeC) recommenda-
tions for animal care with the approval of the UNESC
ethics Committee (protocol number 03/2012). More-
over, all efforts were made to minimise animal suffering
and reduce the number of experimental animals.
Acute GNP administration
Animals received a single intraperitoneal administration
of saline solution, GNPs-10 or GNPs-30, 1 ml kg-1 at
concentrations of 70 mg l-1 and 70 lg kg-1. Twenty-
four hours after administration, the animals were killed
by decapitation, and the blood and liver were isolated for
analysis using the Comet assay.
Chronic GNP administration
Animals received, a once daily for 28 days intraperi-
toneal administration of saline solution (0,9 %), or
GNPs-10 (1 ml�kg-1) or GNPs-30 (1 ml�kg-1) at
concentrations of 70 mg l-1 or 70 lg kg-1. Twenty-
four hours after the final administration, the animals
were killed by decapitation, and the blood and liver
were isolated for analysis of index and frequency of
damage using the Comet assay.
Comet assay
The comet assay was carried out under alkaline
conditions as described by Singh et al. (1988), with
some modifications suggested by Tice et al. (2000).
Cells from different tissues were obtained according to
the modifications suggested by Tice and colleagues.
The blood and livers were placed in cold phosphate-
buffered saline (PBS) and finely minced through a
syringe plungerto obtain cell suspensions. The cells
that were isolated from the tissues (20 ll aliquots)
were embedded in low-melting-point agarose (0.75 %
w/v, 95 ll or 80 ll), and the mixture was added to a
microscope slide pre-coated with normal-melting-
point agarose (1.5 % w/v) and covered with a
coverslip (two slides per donor). Each slide was
briefly placed on ice for the agarose to solidify, and the
coverslip was carefully removed. Each slide was also
immersed in freshly prepared lysis solution (2.5 M
NaCl, 100 mM EDTA, 10 mM Tris; pH 10.0–10.5).
The slides were then incubated in freshly prepared
alkaline buffer solution (300 mM NaOH, 1 mM
EDTA; pH [ 13) for 20 min for DNA unwinding,
and electrophoresis was performed using the same
solution. Electrophoresis was carried out for 15 min at
300 mA and 25 V (0.7 V/cm). All of these steps were
performed under dim, indirect light.
After electrophoresis, the slides were neutralised in
400 mM Tris (pH 7.5). They were stained with silver
nitrate, as described previously by VVillela et al.
(2006), and then fixed for 10 min in a solution
containing 15 % trichloroacetic acid w/v, 5 % zinc
sulphate w/v and 5 % glycerol v/v, rinsed three times
in distilled water and dried for 2 h at 37 �C. The dry
slides were re-hydrated for 5 min in distilled water and
then stained (in 5 % sodium carbonate w/v, 0.1 %
ammonium nitrate w/v, 0.1 % silver nitrate w/v,
0.25 % tungstosilicic acid and 0.15 % formaldehyde
w/v, which was freshly prepared in the dark) and
continuously shaken for 35 min. The stained slides
were then rinsed twice with distilled water, submerged
in the stop solution (1 % acetic acid), rinsed again, and
immediately coded for analysis with an optic micro-
scope. Images of 100 randomly selected cells were
individually analysed. To calculate the damage index
(DI), the cells were visually allocated into five classes
according to tail size (0 = no tails and 4 = maxi-
mum-length tails), which resulted in a single DNA
damage score for each sample, and consequently, for
J Nanopart Res (2014) 16:2727 Page 3 of 8 2727
123
each group studied. Thus, the DI of a group could
range from 0 (completely undamaged = 100
cells 9 0) to 400 (maximum damage = 100
cells 9 4). The damage frequency (DF in percentage)
was calculated for each sample based on the numbers
of cells with versus without tail. International guide-
lines and recommendations for the Comet assay
consider the visual scoring of comets to be a well-
validated evaluation method. This assay has been
demonstrated to have a high correlation value of
1using computer-based image analyses (Collins et al.
1997). Negative and positive controls were used for
each electrophoresis run to ensure the reliability of the
procedure. All slides were coded for a blind analysis.
Statistical analysis
For all analyses of the DNA damage parameters, all
data were expressed as means ± standard deviations.
Statistical analyses of the damage index and damage
frequency, as measured by the Comet assay, were
carried out using one-way analysis of variance
followed by the Tukey test. The analyses were
performed using GraphPad prism version 5.00 for
Windows software.
Results
The results correspondent of characterisation tests of
the GNPs have been published in our previous study
by Cardoso et al. (2014).
Figure 1 shows the comet assay parameters for the
acute treatment with 10 and 30 nm GNP. Animals
treated with 10 nm GNP presented higher DI and DF
values in both evaluated tissues when compared with
the control group (p \ 0.01, ANOVA–Tukey). Treat-
ment with 30 nm GNP showed elevated DI and DF
values in the blood (p \ 0.01, ANOVA–Tukey) and
elevated DI (p \ 0.01, ANOVA–Tukey) and DF
(p \ 0.05, ANOVA–Tukey) values in the liver when
compared with the saline treatment.
The comet assay results for the chronic treatment
with 10 and 30 nm GNP are presented in Fig. 2. The
chronic 10 and 30 nm GNP treatments induced higher
levels of DNA damage, for both DF and DI, in the liver
and blood (p \ 0.01, ANOVA–Tukey) when com-
pared to the control group.
Discussion
The UV–vis spectroscopy and X-ray diffraction
results (showed in Cardoso et al. 2014) agree with
prior studies that showed that the electronic spectra
and, consequently, the colours of colloidal GNP
dispersions depend on the particle geometry and size
(Philip 2008). Colour results from the interactions of
nanoparticle surface electrons with incident light
(Philip 2008; Alkilany and Murphy 2010). The
characteristic SPR band widens and shifts to red and
the XRD peaks narrow as the particle size increases
(Chen et al. 2005; Link and El-Sayed 1999). The
Scherrer equation, based on the most intense peak
(2h = 388), was used to calculate the mean particle
diameters for GNP-10 and GNP-30 dispersions.
Moreover, the XRD spectra of the dried GNPs were
compatible with the standard spectrum of metallic
gold (JCPDS number: 4-0784) (Yan et al. 2005; Singh
et al. 2009; Aromal and Philip 2012).
Morais et al. (2012) evaluated the biodistribution of
GNPs and demonstrated that they are rapidly distrib-
uted, while the liver is the preferential organ of GNP
accumulation. The altered accumulation of GNPs in
various organs and tissues has been related to the size
and surface charge of the NPs that mediate dynamic
protein binding and exchange (Hirn et al. 2011). The
adsorption of plasma proteins onto the surfaces of
NPs, which is known as opsonisation, occurs instantly
when the particles enter the bloodstream (Owens and
Peppas 2006). Considering this and the fact that
oxidative stress can provoke DNA damage, our goal in
this work was to evaluate DNA damage in the blood
and liver of rats after the acute and chronic adminis-
tration of 10 and 30 nm GNPs.
DNA damage is defined as any modification to
DNA that changes its coding properties or the normal
functioning of transcription or replication (Rao 1993;
Morais et al. 2012). Environmental and endogenous
agents, ROS, reactive nitrogen species and other
factors, such as temperature, errors in DNA replication
and repair, and methylation, can lead to damaged
DNA in cells (Tice et al. 2000; Collins 2014). It has
been estimated that metabolism-generated ROS can
cause approximately 10,000 lesions per day in the
genome of a human non-neuronal cell and that purine
base turnover in DNA, resulting from hydrolytic
depurination and its subsequent repair, occurs in
2727 Page 4 of 8 J Nanopart Res (2014) 16:2727
123
approximately 2,000–10,000 bases per day (Rao
1993).
Ours results demonstrated that the acute and
chronic administration of 10 and 30 nm GNPs caused
DNA damage in the blood and liver of the rats, which
was determined using the alkaline comet assay that
measures DNA strand breaks in single cells. The
in vitro study by Kang et al. (2009) showed that DNA
damage did not occur in L5178Y cells containing
GNPs that were 60 nm or smaller GNPs, as
Fig. 1 Effects of the acute
administration of 10 and
30 nm GNPs on the damage
index and damage frequency
(mean ± SD) in the liver
(a–b) and peripheral blood
(c–d) of rats. *Data
significantly differ in
relation to the control group
(p \ 0.05, ANOVA–
Tukey). **Data significantly
differ in relation to the
control group (p \ 0.01,
ANOVA–Tukey)
Fig. 2 Effects of the
chronic administration of 10
and 30 nm GNPs on the
damage index and damage
frequency (mean ± SD) in
the liver (a–b) and
peripheral blood (c–d) of
rats. **Data significantly
differ in relation to the
control group (p \ 0.01,
ANOVA–Tukey)
J Nanopart Res (2014) 16:2727 Page 5 of 8 2727
123
determined by the Comet assay; damage only occurred
with 100 nm GNPs. However, other studies have
reported DNA damage in association with 20 nm (Li
et al. 2008) and 8 nm (Auffan et al. 2009) GNPs,
although no damage was reported in a study using
10 nm GNPs (Singh et al. 2010).
Hillyer and Albrecht (2001) showed that after
administration, GNPs appeared in various tissues in
mice and that the amount of absorption and distribu-
tion in the body inversely correlated with the size of
the particles and surface properties. However, in our
study was demonstrated that both sizes of GNP
analysed (10 and 30 nm) caused DNA damage.
Additionally, studies have demonstrated binding
affinities between GNP and thiol and amine groups
that promote combinations with biomolecules (Katz
and Willner 2004; Ojea-Jimenez and Puntes 2009) and
the free radical formation due to GNP (Siddiqi et al.
2012). Previous works show that the very large surface
areas of ultra-small particles can result in the direct
formation of ROS that can cause cellular damage by
attacking DNA, proteins and membranes and affect
the cytoplasm, mitochondrial function and the nucleus
(Brown et al. 2001; Lewinski et al. 2008). Therefore,
oxidative stress is a possible mechanism for induced
toxicity by acute and chronic administration of GNP of
10 and 30 nm on DNA.
Additionally, GNPs can cause the generation of
caspase-3, interferon-c and 8-hydroxydeoxyguanosine
(8OHdG), which may lead to inflammation and DNA
damage/cell death, which was also demonstrated in the
recent study by Cardoso et al. (2014). Thus, oxidative
stress has been emphasized as a likely mechanism of NP
toxicity (Li et al. 2008), and it may be hypothesised from
the present results that DNA damage results from the
excessive production of free radicals, generating oxida-
tive damage to cells (Halliwell and Gutteridge 2001). In
addition, studies involving experimental animals have
shown that augmented ROS, and particularly superox-
ide (•O2–), can interact with DNA, resulting in oxidative
damage and DNA fragmentation-mediated cellular
injury (Gill and Wilcox 2006; Touyz 2004; Zhong and
Xu 2008; Madsen-Bouterse et al. 2010). Chueh et al.
(2014) showed that genes involved in BER and
homologous recombination pathways were significantly
enhanced by GNPs, indicating that intracellular GNPs
may cause base damage. Considering these data collec-
tively, we presume that DNA damage is likely to be
related to blood GNP levels, which may explain the
effects of GNPs on the DNA in the blood and liver of rats
after the acute and chronic administration of GNPs of
different diameters. Although our previous study has
demonstrated differences related to chronic and acute
treatments in cerebral cortex (Cardoso et al. 2014), the
present study not shows difference between these
administrations in the blood and liver. So, we suggest
that GNPs have easy access to blood and liver, since that
not present neither impediment, as the blood brain
barrier.
Conclusions
In conclusion, the present study demonstrated that the
acute and chronic administration of 10 and 30 nm
GNPs caused DNA damage in the blood and liver of
the treated rats. These findings suggest that the DNA
damage may be caused by oxidative stress, which
occurs regardless of the type of administration and the
size of the GNP.
Acknowledgments This work was supported by grants from
Conselho Nacional de Pesquisa e Desenvolvimento (CNPq),
CAPES and the Universidade do Extremo Sul Catarinense
(UNESC). The authors would also like to thank CNPq and
UNESC for the fellowship support.
References
Alkilany AM, Murphy CJ (2010) Toxicity and cellular uptake of
gold nanoparticles: what we have learned so far? J Nano-
particle 12:2313–2333
Aromal SA, Philip D (2012) Green synthesis of gold nanopar-
ticles using Trigonella foenum-graecum and its size-
dependent catalytic activity. Spectrochimistry Acta 97:1–5
Aschner M (2009) Chapter 8 - nanoparticles: transport across
the olfactory epithelium and application to the assessment
of brain function in health and disease. Prog Brain Res
180:141–152
Auffan M, Rose J, Orsiere T, De Meo M, Thill A, Zeyons O,
Proux O, Masion A, Chaurand P, Spalla O (2009) CeO2
nanoparticles induce DNA damage towards human dermal
fibroblasts in vitro. Nanotoxicology 3:161–171
Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K
(2001) Size-dependent proinflammatory effects of ultrafine
polystyrene particles: a role for surface area and oxidative
stress in the enhanced activity of ultrafines. Toxicol Appl
Pharmacol 175:191–199
Butterfield DA, Stadtman ER (1997) Protein oxidation pro-
cesses in aging brain. Adv Cell Aging Gerontol 2:161–191
Cardoso E, Rezin GT, Zanoni ET, Notoya FS, Leffa DD,
Damiani AP, Daumann F, Rodriguez JCO, Benavides R,
2727 Page 6 of 8 J Nanopart Res (2014) 16:2727
123
Silva L (2014) Acute and chronic administration of gold
nanoparticles cause dna damage in the cerebral cortex of
adult rats. Mutat Res 766–767:25–30
Chen Y, Gu X, Nie CG, Jiang ZY, Xie ZX, Lin CJ (2005) Shape
controlled growth of gold nanoparticles by a solution
synthesis. Chem Commun 33:4181–4183
Chithrani BD, Chan WC (2007) Elucidating the mechanism of
cellular uptake and removal of protein-coated gold nano-
particles of different sizes and shapes. Nano Lett
7:1542–1550
Chueh PJ, Liang RY, Lee YH, Zeng ZM, Chuang SM (2014)
Differential cytotoxic effects of gold nanoparticles in dif-
ferent mammalian cell lines. J Hazard Mater 264:303–312
Collins AR (2014) Measuring oxidative damage to DNA and its
repair with the comet assay. Biochim Biophys Acta
1840:794–800
Collins A, Dusinska M, Franklin M, Somorovska M, Petrovska
H, Duthie S, Fillion L, Panayiotidis M, Raslova K,
Vaughan N (1997) Comet assay in human biomonitoring
studies: reliability, validation, and applications. Environ
Mol Mutagen 30:139–146
Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD (2005)
Gold nanoparticles are taken up by human cells but do not
cause acute cytotoxicity. Small 1:325–327
CooperaStevenson P (1951) A study of the nucleation and
growth processes in the synthesis of colloidal gold. Discuss
Faraday Soc 11:55–75
de Lamirande E, Gagnon C (1993) Human sperm hyperactiva-
tion in whole semen and its association with low super-
oxide scavenging capacity in seminal plasma. Fertil Steril
59:1291–1295
Gill PS, Wilcox CS (2006) NADPH oxidases in the kidney.
Antioxid Redox Signal 8:1597–1607
Halliwell B, Gutteridge JMC (2001) Oxidative stress: adapta-
tion, damage, repair and death. In: Halliwell B, Gutteridge
JMC (eds) Free radicals in biology and medicine. Oxford
University Press, Oxford, pp 246–350
Hillyer JF, Albrecht RM (2001) Gastrointestinal persorption and
tissue distribution of differently sized colloidal gold
nanoparticles. J Pharm Sci 90:1927–1936
Hirn S, Semmler-Behnke M, Schleh C, Wenk A, Lipka J,
Schaffler M, Takenaka S, Moller W, Schmid G, Simon U,
Kreyling WG (2011) Particle size-dependent and surface
charge-dependent biodistribution of gold nanoparticles
after intravenous administration. Eur J Pharm Biopharm
77:407–416
Kang SJ, Yum YN, Kim JH, Song H, Jeong J, Lim YT, Chung
BH, Park SN (2009) Induction of DNA damage in L5178Y
cells treated with gold nanoparticle. Biomol Ther 17:6
Karihtala P, Soini Y, Vaskivuo L, Bloigu R, Puistola U (2009)
DNA adduct 8-hydroxydeoxyguanosine, a novel putative
marker of prognostic significance in ovarian carcinoma. Int
J Gynecol Cancer 19:1047–1051
Katz E, Willner I (2004) Integrated nanoparticle-biomolecule
hybrid systems: synthesis, properties, and applications.
Angew Chem Int 43:6042–6108
Lewinski N, Colvin V, Drezek R (2008) Cytotoxicity of nano-
particles. Small 4:26–49
Li JJ, Zou L, Hartono D, Ong CN, Bay BH, Lanry Yung LY
(2008) Gold nanoparticles induce oxidative damage in lung
fibroblasts in vitro. Adv Mater 20:138–142
Link S, El-Sayed MA (1999) Size and temperature dependence
of the plasmon absorption of colloidal gold nanoparticles.
J Phys Chem B103:4212–4217
Liu Z, Martin LJ (2001) Motor neurons rapidly accumulate
DNA single-strand breaks after in vitro exposure to nitric
oxide and peroxynitrite and in vivo axotomy. J Comp
Neurol 432:35–60
Madsen-Bouterse SA, Zhong Q, Mohammad G, Ho YS,
Kowluru RA (2010) Oxidative damage of mitochondrial
DNA in diabetes and its protection by manganese super-
oxide dismutase. Free Radic Res 44:313–321
Martin LJ, Liu Z (2002) DNA damage profiling in motor neu-
rons: a single-cell analysis by comet assay. Neurochem Res
27:1093–1104
Merchant B (1998) Gold, the noble metal and the paradoxes of
its toxicology. Biologicals 26:49–59
Morais T, Soares ME, Duarte JA, Soares L, Maia S, Gomes P,
Pereira E, Fraga S, Carmo H, Bastos Mde L (2012) Effect
of surface coating on the biodistribution profile of gold
nanoparticles in the rat. Eur J Pharm Biopharm 80:185–193
Ng CT, Li JJ, Bay BH, Yung LY (2010) Current studies into the
genotoxic effects of nanomaterials. J Nucleic Acids
21:2010
Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitz-
patrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D,
Olin S, Monteiro-Riviere N, Warheit D, Yang H (2005)
Principles for characterizing the potential human health
effects from exposure to nanomaterials: elements of a
screening strategy. Part Fibre Toxicol 2:8
Ojea-Jimenez I, Puntes V (2009) Instability of cationic gold
nanoparticle bioconjugates: the role of citrate ions. J Am
Chem Soc 131:13320–13327
Owens DE, Peppas NA (2006) Opsonization, biodistribution,
and pharmacokinetics of polymeric nanoparticles. Int J
Pharm 307:93–102
Pan Y, Neuss S, Leifert A, Fischler M, Wen F, Simon U, Schmid
G, Brandau W, Jahnen-Dechent W (2007) Size-dependent
cytotoxicity of gold nanoparticles. Small 3:1941–1949
Pernodet N, Fang X, Sun Y, Bakhtina A, Ramakrishnan A,
Sokolov J, Ulman A, Rafailovich M (2006) Adverse effects
of citrate/gold nanoparticles on human dermal fibroblasts.
Small 2:766–773
Philip D (2008) Synthesis and spectroscopic characterization of
gold nanoparticles. Spectrochim Acta 71:80–85
Porter AG, Janicke RU (1999) Emerging roles of caspase-3 in
apoptosis. Cell Death Differ 6:99–104
Rao KS (1993) Genomic damage and its repair in young and
aging brain. Mol Neurobiol 7:23–48
Sadauskas E, Wallin H, Stoltenberg M, Vogel U, Doering P,
Larsen A, Danscher G (2007) Kupffer cells are central in
the removal of nanoparticles from the organism. Part Fibre
Toxicol 4:10
Sadauskas E, Danscher G, Stoltenberg M, Vogel U, Larsen A,
Wallin H (2009) Protracted elimination of gold nanopar-
ticles from mouse liver. Nanomedicine 5:162–169
Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, Sastry
M (2005) Biocompatibility of gold nanoparticles and their
endocytotic fate inside the cellular compartment: a
microscopic overview. Langmuir 21:10644–10654
Siddiqi NJ, Abdelhalim MA, El-Ansary AK, Alhomida AS, Ong
WY (2012) Identification of potential biomarkers of gold
J Nanopart Res (2014) 16:2727 Page 7 of 8 2727
123
nanoparticle toxicity in rat brains. J Neuroinflammation
9:123
Singh NP, McCoy MT, Tice RR, Schneider EL (1988) A simple
technique for quantitation of low levels of DNA damage in
individual cells. Exp Cell Res 175:184–191
Singh P, Kumari K, Katyal A, Kalra R, Chandra R (2009)
Synthesis and characterization of silver and gold nano-
particles in ionic liquid. Spectrochim Acta A73:218–220
Singh S, D’Britto V, Prabhune A, Ramana A, Dhawan A, Prasad
B (2010) Cytotoxic and genotoxic assessment of glyco-
lipid-reduced and-capped gold and silver nanoparticles.
New J Chem 34:294–301
Sonavane G, Tomoda K, Makino K (2008) Biodistribution of
colloidal gold nanoparticles after intravenous administra-
tion: effect of particle size. Colloids Surf B Biointerfaces
66:274–280
Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A,
Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF
(2000) Single cell gel/comet assay: guidelines for in vitro
and in vivo genetic toxicology testing. Environ Mol
Mutagen 35:206–221
Touyz RM (2004) Reactive oxygen species and angiotensin II
signaling in vascular cells–implications in cardiovascular
disease. Braz J Med Biol Res 37:1263–1273
Villela IV, de Oliveira IM, da Silva J, Henriques JA (2006) DNA
damage and repair in haemolymph cells of golden mussel
(Limnoperna fortunei) exposed to environmental contam-
inants. Mutat Res 605:78–86
Yan WF, Petkov V, Mahurin SM, Overbury SH, Dai S (2005)
Powder XRD analysis and catalysis characterization of
ultra-small gold nanoparticles deposited on titania-modi-
fied SBA-15. Catalisys Commun 6:404–408
Zhang XD, Wu HY, Wu D, Wang YY, Chang JH, Zhai ZB,
Meng AM, Liu PX, Zhang LA, Fan FY (2010) Toxicologic
effects of gold nanoparticles in vivo by different adminis-
tration routes. Int J Nanomedicine 5:771–781
Zhong N, Xu J (2008) Synergistic activation of the human
MnSOD promoter by DJ-1 and PGC-1alpha: regulation by
SUMOylation and oxidation. Hum Mol Genet
17:3357–3367
2727 Page 8 of 8 J Nanopart Res (2014) 16:2727
123